section name header

Basics

[Show Section Outline]

DESCRIPTION

Chromium is widely used in the metallurgical, refractory, and chemical industries as well as the tanning industry, pigment production, graphics, and many others.

FORMS AND USES

TOXIC DOSE

The lethal oral adult dose of has been estimated to be between 0.5 and 1.0 g of hexavalent chromium.

PATHOPHYSIOLOGY

EPIDEMIOLOGY

CAUSES

WORKPLACE STANDARDS

For hexavalent chromium, expressed as chromium:


Section Outline:

Diagnosis

[Show Section Outline]

DIFFERENTIAL DIAGNOSIS

Other causes of caustic skin or gastrointestinal injury include acidic or basic corrosives.

SIGNS AND SYMPTOMS

Systemic effects resulting from acute ingestion include circulatory collapse, shock, and death.

Dermatologic

Pulmonary

Gastrointestinal

Following ingestion, oral and gastrointestinal burns with hemorrhage are common.

Hepatic

Systemic effects resulting from acute ingestion include acute hepatitis.

Renal

Systemic effects resulting from acute ingestion include renal failure.

Hematologic

Systemic effects resulting from acute ingestion include thrombocytopenia and anemia.

Neurologic

Systemic effects resulting from acute ingestion include encephalopathy.

PROCEDURES AND LABORATORY TESTS

Essential Tests

No tests may be needed in asymptomatic patients.

Recommended Tests

Not Recommended Tests

Blood or serum levels have not been found to be clinically useful.


Section Outline:

Treatment

[Show Section Outline]

Treatment should focus on general supportive care and decontamination.

DIRECTING PATIENT COURSE

The health-care professional should call the poison control center when:

Patients should be referred to a health-care facility when:

Admission Considerations

Inpatient management in an intensive care setting is warranted for symptomatic patients after ingestion.

DECONTAMINATION

Ingestion

Dermal

The skin should be washed copiously with tepid water and soaked in a 10% to 20% solution of ascorbic acid for 15 minutes.

ANTIDOTES

Dimercaprol (British anti-Lewisite), a heavy metal chelator, has been used successfully in some cases.

ADJUNCTIVE TREATMENT


Section Outline:

FollowUp

[Show Section Outline]

PATIENT MONITORING

Respiratory and cardiac monitoring should be performed continuously in symptomatic patients.

EXPECTED COURSE AND PROGNOSIS

DISCHARGE CRITERIA/INSTRUCTIONS


Section Outline:

Pitfalls

FOLLOW-UP

Grade II or III esophageal burns need follow-up gastrointestinal series to detect strictures.

Miscellaneous

ICD-9-CM 985.6

Toxic effect of other metals: chromium.

See Also: SECTION III, British Anti-Lewisite (dimercaprol); SECTION IV, Caustics—Acidic.

RECOMMENDED READING

Deng JF, Fleeger AK, Sinks T. An outbreak of chromium ulcer in a manufacturing plant. Vet Human Tox 1990;32:142-146.

Authors: Scott D. Phillips and Melanie A. Wells

Reviewer: Richard C. Dart